+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Caladrius Biosciences Inc (CLBS) - Financial and Strategic SWOT Analysis Review

  • ID: 4285241
  • SWOT Analysis
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc is a clinical stage development company that develops and manufactures cell therapy products. The company’s products are based on its proprietary technologies such as Dendritic Cell-Tumor Cell technology; CD34 technology; and T Regulatory technology, for immuno-oncology, ischemic repair and immunomodulation. Its developmental pipeline products include CLBS20 (NBS20) for the treatment of metastatic melanoma, CLBS10 (formerly NBS10) for ST-elevation myocardial infarction and CLBS03 for type 1 diabetes. It offers services comprising product and process development, engineering and automation, GMP manufacturing, cell and tissue processing, storage and distribution, and expert consulting and regulatory support. The company caters to biotechnology, pharmaceutical and medical product companies, and academic research institutions. It operates in Basking Ridge, Irvine and New York, the US. Caladrius is headquartered in Basking Ridge, New Jersey, the US.

Caladrius Biosciences Inc Key Recent Developments

Nov 09, 2017: Caladrius Biosciences Reports 2017 Third Quarter Results
Aug 10, 2017: Caladrius Biosciences Reports 2017 Second Quarter Results
Jun 14, 2017: Invetech and Caladrius Biosciences Receive 2017 Good Design Award for Design of a Counterflow Centrifuge Device for use in the Development of Cell Therapies
May 15, 2017: Caladrius Biosciences Announces 2017 First Quarter Financial Results
May 01, 2017: Caladrius Biosciences to Participate at Upcoming May Conferences

This comprehensive SWOT profile of Caladrius Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Caladrius Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Caladrius Biosciences Inc - Key Information
  • Caladrius Biosciences Inc - Overview
  • Caladrius Biosciences Inc - Key Employees
  • Caladrius Biosciences Inc - Key Employee Biographies
  • Caladrius Biosciences Inc - Key Operational Heads
  • Caladrius Biosciences Inc - Major Products and Services
  • Caladrius Biosciences Inc - History
  • Caladrius Biosciences Inc - Company Statement
  • Caladrius Biosciences Inc - Locations And Subsidiaries
  • Caladrius Biosciences Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Caladrius Biosciences Inc - Business Description
  • Caladrius Biosciences Inc - Corporate Strategy
  • Caladrius Biosciences Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Caladrius Biosciences Inc - Strengths
  • Caladrius Biosciences Inc - Weaknesses
  • Caladrius Biosciences Inc - Opportunities
  • Caladrius Biosciences Inc - Threats
  • Caladrius Biosciences Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Caladrius Biosciences Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Caladrius Biosciences Inc, Key Information
  • Caladrius Biosciences Inc, Key Ratios
  • Caladrius Biosciences Inc, Share Data
  • Caladrius Biosciences Inc, Major Products and Services
  • Caladrius Biosciences Inc, History
  • Caladrius Biosciences Inc, Key Employees
  • Caladrius Biosciences Inc, Key Employee Biographies
  • Caladrius Biosciences Inc, Key Operational Heads
  • Caladrius Biosciences Inc, Other Locations
  • Caladrius Biosciences Inc, Subsidiaries
  • Caladrius Biosciences Inc, Key Manufacturing facilities
  • Caladrius Biosciences Inc, Key Competitors
  • Caladrius Biosciences Inc, SWOT Analysis
  • Caladrius Biosciences Inc, Ratios based on current share price
  • Caladrius Biosciences Inc, Annual Ratios
  • Caladrius Biosciences Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Caladrius Biosciences Inc, Performance Chart
  • Caladrius Biosciences Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3